IgG and IgM markers in lupus disease activity
Part of Immune system & allergy, Skin clinical trials.
This study looks at two blood markers (IgG and IgM) in people with lupus to see if they can help measure disease activity and damage. It may help doctors better understand and manage lupus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with systemic lupus erythematosus (SLE) using the 2019 ACR/EULAR criteria.
- You do not have other autoimmune diseases such as systemic sclerosis, Sjögren’s syndrome, rheumatoid arthritis, dermatomyositis, or mixed connective tissue disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.
This study looks for certain immune markers (HLA antibodies) in stored blood samples from people with lupus. It may help doctors understand how the immune system behaves in lupus.
This study looks at whether two blood markers (AGR and PNI) can help track how active lupus is. You may be eligible if you have lupus and are not pregnant or have other serious health conditions.
This study looks at a protein called CXCL5 in the blood of people with lupus (SLE) to see if it relates to how active their disease is. It will help researchers understand more about lupus and possibly find new ways to track or treat it.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.